# Probiotic Engineering Agent

**ID:** `biomedical.microbiome.probiotic_engineering`
**Version:** 1.0.0
**Status:** Experimental
**Category:** Microbiome / Synthetic Biology

---

## Overview

The **Probiotic Engineering Agent** designs genetically engineered probiotic strains with enhanced therapeutic capabilities. Using CRISPR-based gene editing and synthetic biology, this agent creates designer probiotics that can sense disease biomarkers, produce therapeutic molecules, and modulate host immunity.

This represents the convergence of microbiome science and synthetic biology, enabling next-generation live biotherapeutics with programmable functions.

---

## Key Capabilities

### 1. Engineering Platforms

| Organism | Advantages | Applications |
|----------|------------|--------------|
| **E. coli Nissle 1917** | Genetic tools, colonization | Drug delivery |
| **Lactobacillus spp.** | GRAS, food-grade | Oral therapeutics |
| **Bacteroides spp.** | Gut-resident, stable | Long-term colonization |
| **Saccharomyces boulardii** | Yeast, eukaryotic tools | Enzyme delivery |

### 2. Therapeutic Functions

| Function | Mechanism | Example |
|----------|-----------|---------|
| **Drug production** | Heterologous expression | IL-10, GLP-1 |
| **Metabolite synthesis** | Pathway engineering | Butyrate, tryptophan |
| **Toxin neutralization** | Binding/degradation | C. diff toxin |
| **Biomarker sensing** | Genetic circuits | Cancer detection |

### 3. Genetic Tools

- **CRISPR-Cas9:** Gene knockout and insertion
- **Integrase systems:** Stable chromosomal integration
- **Inducible promoters:** Controlled expression
- **Biosensors:** Environmental response

### 4. Safety Features

| Feature | Mechanism | Purpose |
|---------|-----------|---------|
| **Auxotrophy** | Essential gene deletion | Biocontainment |
| **Kill switch** | Conditional cell death | Environmental control |
| **Genetic stability** | Chromosomal integration | Plasmid-free |

---

## Usage

### Example Prompt

```text
Design an engineered E. coli Nissle 1917 strain that:
1. Senses inflammatory markers (tetrathionate - indicator of gut inflammation)
2. Responds by producing human IL-10 (anti-inflammatory)
3. Includes auxotrophy for biocontainment
4. Uses chromosomal integration for stability
```

### Expected Output

```
## Engineered Probiotic Design: EcN-SenseInflam

### Design Overview
- **Chassis:** E. coli Nissle 1917
- **Function:** Inflammation-responsive IL-10 production
- **Biosensor:** Tetrathionate (gut inflammation marker)
- **Therapeutic:** Human IL-10 secretion

### Genetic Circuit Design

```
Tetrathionate (inflammation)
    ↓
TtrSR two-component system
    ↓
PttrB promoter activation
    ↓
Human IL-10 + secretion tag
    ↓
IL-10 secreted → anti-inflammatory effect
```

### Genetic Parts

#### 1. Sensor Module (Chromosomal - attB site)
```
[PttrS]-[ttrS]-[ttrR]-[terminator]

- ttrS: Sensor histidine kinase
- ttrR: Response regulator
- Location: Integrated at λ attB
```

#### 2. Response Module (Chromosomal - HK022 attB)
```
[PttrB]-[RBS]-[pelB-hIL10]-[terminator]

- PttrB: Tetrathionate-inducible promoter
- pelB: Periplasmic secretion signal
- hIL10: Human IL-10 (codon optimized)
- Location: Integrated at HK022 attB
```

### Sequence Details

#### Human IL-10 (Codon Optimized for E. coli)
```
>hIL10_ecoli_optimized
ATGAGCCACGAACTGCTGACCACCCTGCCGCTGTTCCTGGTGCTGGAAA
ACCCGAACGCGATCAACGAAGACCTGAAAAACATCTTTAAAGCGAAATT
CAAACGTCTGCTGGGCTGCCTGGAAGGCATCCACGAAAGCGCGAACGAA
GCGCTGCGTCACCTGCTGAAACGTCAGCGTCTGATCCTGCAGCGTCTGG
GCGAACTGAAAGCGGAACTGCCGTGCATCGAAATCATCAAATACAAAGC
GATGAAAGCGTGCCTGAACGCGCTGTCGCGTAACCTGAAACTGCGTAAA
CTGAAACAGATCAACGAACTGCTGCAGGAA...
```

#### Secretion Signal (PelB)
```
ATGAAATACCTGCTGCCGACCGCTGCTGCTGGTCTGCTGCTCCTCGCTG
CCCAGCCGGCGATGGCC
```

### Biocontainment Features

#### DAP Auxotrophy (ΔdapA)
```
Modification: Delete dapA (diaminopimelate synthesis)
Effect: Requires exogenous DAP for survival
Containment: Cannot survive outside lab/GI tract
```

#### Kill Switch (optional enhancement)
```
Module: Toxin-antitoxin system
Trigger: Absence of arabinose or IPTG
Purpose: Additional safety layer
```

### Performance Predictions

| Condition | IL-10 Production | Growth |
|-----------|------------------|--------|
| No tetrathionate | <5 ng/mL | Normal |
| Low tetrathionate (10 μM) | 50-100 ng/mL | Normal |
| High tetrathionate (100 μM) | 200-500 ng/mL | Normal |

### Construction Protocol

#### Phase 1: Chromosome Integration
1. **Clone sensor module** into pOSIP-KO (λ integration)
2. **Transform** EcN, select KanR
3. **Cure plasmid**, verify by PCR

#### Phase 2: Response Module
1. **Clone IL-10 module** into pOSIP-CH (HK022 integration)
2. **Transform** Phase 1 strain, select CmR
3. **Cure plasmid**, verify by PCR

#### Phase 3: Auxotrophy
1. **P1 transduce** ΔdapA::FRT from Keio collection
2. **Cure FRT marker** with FLP recombinase
3. **Verify** DAP requirement

### Safety Assessment

| Criterion | Status | Notes |
|-----------|--------|-------|
| Parental strain safety | GRAS | E. coli Nissle approved probiotic |
| Horizontal gene transfer | Low risk | Chromosomal integration |
| Environmental persistence | Contained | DAP auxotrophy |
| Antibiotic resistance | None | Marker-free final strain |

### Testing Plan

| Test | Method | Success Criterion |
|------|--------|-------------------|
| Tetrathionate response | ELISA for IL-10 | >10x induction |
| Gut colonization | Mouse model | Detectable at 7 days |
| Anti-inflammatory effect | DSS colitis model | Reduced DAI score |
| Biocontainment | Survival assay | No growth without DAP |
```

### LLM Agent Integration

```python
@tool
def design_engineered_probiotic(
    chassis: str,
    sensor_input: str,
    therapeutic_output: str,
    biocontainment: list[str] = ["auxotrophy"],
    integration_type: str = "chromosomal"
) -> str:
    """
    Designs engineered probiotic strain with therapeutic function.

    Args:
        chassis: Host organism (EcN, lactobacillus, bacteroides)
        sensor_input: Environmental signal to sense
        therapeutic_output: Therapeutic molecule to produce
        biocontainment: Safety features (auxotrophy, kill_switch)
        integration_type: chromosomal or plasmid

    Returns:
        Strain design with genetic circuits and protocols
    """
    pass
```

---

## References

- **Riglar et al. (2017):** "Engineered bacteria can function in the mammalian gut long-term as live diagnostics." *Nature Biotechnology*
- **Isabella et al. (2018):** "Development of a synthetic live bacterial therapeutic for PKU." *Nature Biotechnology*

---

## Author

**MD BABU MIA**
*Artificial Intelligence Group*
*Icahn School of Medicine at Mount Sinai*
md.babu.mia@mssm.edu
